BioSpace News Archive

Thermo Fisher Scientific, the world leader in serving science, will demonstrate the benefits of collaborating to advance the science of transplantation and connecting breakthroughs to patients this week at the 48th Annual Meeting of the American Society for Histocompatibility & Immunogenetics Conference in Las Vegas.

JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement systems, announced that Duane Pinto, MD, MPH, has been appointed as Chief Medical Officer.

Clinicians with the Gastrointestinal Eosinophilic Disease Program at the Digestive Health Institute, Children’s Hospital of Colorado, performed the Esophageal String Test® on a patient in early September.

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, announced the five posters presented at the American College of Gastroenterology 2022 Annual Scientific Meeting, which is being held in Charlotte, NC and virtually from October 21–26, 2022.

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at two investor conferences in November 2022.

Cyclacel Pharmaceuticals, Inc. announced that it will host a research and development day, featuring key opinion leaders, with a focus on the Company’s CDK2/9 inhibitor, oral fadraciclib, and PLK1 inhibitor, oral CYC140, on Monday, October 31, 2022 at 10:00 am Eastern Time.

Therapeutic Solutions International (TSOI) announced today successful administration of JadiCells into a treatment resistant epilepsy patient resulting in a profound recovery.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today plans to establish a new, separate manufacturing facility to be located in Suffolk County, New York, for the enzymatic production of cGMP LinearDNA™ for use in genetic medicines.

ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, recently announced the appointment of Dr. Sridhar Narayan as Vice President responsible for the global Medicinal Chemistry team.

Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, recently announced the appointment of Kety Duron as chief human resources officer (CHRO).